{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:04:42Z","timestamp":1776704682919,"version":"3.51.2"},"publisher-location":"Cham","reference-count":43,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030105600","type":"print"},{"value":"9783030105617","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/164_2018_134","type":"book-chapter","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T06:16:49Z","timestamp":1534918609000},"page":"461-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project"],"prefix":"10.1007","author":[{"given":"Anders","family":"Helander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda","family":"B\u00e4ckberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"134_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jchromb.2013.04.043","volume":"930","author":"Y Al-Saffar","year":"2013","unstructured":"Al-Saffar Y, Stephanson NN, Beck O (2013) Multicomponent LC-MS\/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 930:112\u2013120","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"134_CR2","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/jms.1558","volume":"44","author":"V Auw\u00e4rter","year":"2009","unstructured":"Auw\u00e4rter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N (2009) \u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832\u2013837","journal-title":"J Mass Spectrom"},{"key":"134_CR3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/15563650.2014.920088","volume":"52","author":"M B\u00e4ckberg","year":"2014","unstructured":"B\u00e4ckberg M, Beck O, Hulten P, Rosengren-Holmberg J, Helander A (2014) Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): a case series from the Swedish STRIDA project. Clin Toxicol (Phila) 52:618\u2013624","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3109\/15563650.2015.1079325","volume":"53","author":"M B\u00e4ckberg","year":"2015","unstructured":"B\u00e4ckberg M, Beck O, Helander A (2015a) Phencyclidine analog use in Sweden \u2013 intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clin Toxicol (Phila) 53:856\u2013864","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/15563650.2015.1054505","volume":"53","author":"M B\u00e4ckberg","year":"2015","unstructured":"B\u00e4ckberg M, Beck O, J\u00f6nsson KH, Helander A (2015b) Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clin Toxicol (Phila) 53:609\u2013617","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/15563650.2014.981823","volume":"53","author":"M B\u00e4ckberg","year":"2015","unstructured":"B\u00e4ckberg M, Lindeman E, Beck O, Helander A (2015c) Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 53:46\u201353","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/15563650.2016.1211288","volume":"54","author":"M B\u00e4ckberg","year":"2016","unstructured":"B\u00e4ckberg M, Westerbergh J, Beck O, Helander A (2016) Adverse events related to the new psychoactive substance 3-fluorophenmetrazine \u2013 results from the Swedish STRIDA project. Clin Toxicol (Phila) 54:819\u2013825","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s13181-016-0584-2","volume":"13","author":"M B\u00e4ckberg","year":"2017","unstructured":"B\u00e4ckberg M, Tworek L, Beck O, Helander A (2017) Analytically confirmed intoxications involving MDMB-CHMICA from the STRIDA project. J Med Toxicol 13:52\u201360","journal-title":"J Med Toxicol"},{"key":"134_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/dta.2226","volume":"10","author":"M B\u00e4ckberg","year":"2018","unstructured":"B\u00e4ckberg M, J\u00f6nsson KH, Beck O, Helander A (2018) Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Test Anal 10:340\u2013349","journal-title":"Drug Test Anal"},{"key":"134_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/dta.274","volume":"3","author":"M Baron","year":"2011","unstructured":"Baron M, Elie M, Elie L (2011) An analysis of legal highs: do they contain what it says on the tin? Drug Test Anal 3:576\u2013581","journal-title":"Drug Test Anal"},{"key":"134_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","volume":"53","author":"O Beck","year":"2015","unstructured":"Beck O, Franzen L, B\u00e4ckberg M, Signell P, Helander A (2015) Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project. Clin Toxicol (Phila) 53:865\u2013873","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/15563650.2016.1190979","volume":"54","author":"O Beck","year":"2016","unstructured":"Beck O, Franzen L, B\u00e4ckberg M, Signell P, Helander A (2016) Toxicity evaluation of alpha-pyrrolidinovalerophenone (alpha-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol (Phila) 54:568\u2013575","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jchromb.2009.03.004","volume":"877","author":"K Bj\u00f6rnstad","year":"2009","unstructured":"Bj\u00f6rnstad K, Beck O, Helander A (2009) A multi-component LC-MS\/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr B Analyt Technol Biomed Life Sci 877:1162\u20131168","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"134_CR14","unstructured":"Bradley M, Hasselblad A, Norlen L, Lapins J, B\u00e4ckberg M, Helander A (2016) Acute cutaneous symptom complex with subsequent cataract. The internet drug MT-45 may be the cause. Lakartidningen 113. DTAF"},{"key":"134_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","volume":"103","author":"S Davies","year":"2010","unstructured":"Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI (2010) Purchasing \u2018legal highs\u2019 on the internet \u2013 is there consistency in what you get? QJM 103:489\u2013493","journal-title":"QJM"},{"key":"134_CR16","unstructured":"Drug Enforcement Administration (2016) Counterfeit prescription pills containing fentanyls: a global threat. \n                  https:\/\/www.dea.gov\/docs\/Counterfeit%20Prescription%20Pills.pdf"},{"key":"134_CR17","unstructured":"EMCDDA (2009) Understanding the \u2018Spice\u2019 phenomenon. \n                  http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_80086_EN_EMCDDA_Understanding%20the%20%E2%80%98Spice%E2%80%99%20phenomenon_4Update%2020090813.pdf"},{"key":"134_CR18","unstructured":"EMCDDA (2017) European drug report 2017: trends and developments. \n                  http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4541\/TDAT17001ENN.pdf"},{"key":"134_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Seth P (2016) Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths \u2013 27 states, 2013\u20132014. MMWR Morb Mortal Wkly Rep 65:837\u2013843","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"134_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650.2016.1217003","volume":"55","author":"A Helander","year":"2016","unstructured":"Helander A, B\u00e4ckberg M (2016) New Psychoactive Substances (NPS) \u2013 the Hydra monster of recreational drugs. Clin Toxicol (Phila) 55(1):1\u20133","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00365513.2013.793817","volume":"73","author":"A Helander","year":"2013","unstructured":"Helander A, Beck O, H\u00e4gerkvist R, Hulten P (2013) Identification of novel psychoactive drug use in Sweden based on laboratory analysis \u2013 initial experiences from the STRIDA project. Scand J Clin Lab Invest 73:400\u2013406","journal-title":"Scand J Clin Lab Invest"},{"key":"134_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/15563650.2014.943908","volume":"52","author":"A Helander","year":"2014","unstructured":"Helander A, B\u00e4ckberg M, Beck O (2014a) MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 52:901\u2013904","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.forsciint.2014.02.022","volume":"243","author":"A Helander","year":"2014","unstructured":"Helander A, B\u00e4ckberg M, Hulten P, Al-Saffar Y, Beck O (2014b) Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int 243:23\u201329","journal-title":"Forensic Sci Int"},{"key":"134_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/15563650.2015.1033630","volume":"53","author":"A Helander","year":"2015","unstructured":"Helander A, Beck O, B\u00e4ckberg M (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clin Toxicol (Phila) 53:446\u2013453","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/15563650.2016.1139715","volume":"54","author":"A Helander","year":"2016","unstructured":"Helander A, B\u00e4ckberg M, Beck O (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol (Phila) 54:324\u2013332","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR26","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/bjd.15174","volume":"176","author":"A Helander","year":"2017","unstructured":"Helander A, Bradley M, Hasselblad A, Norlen L, Vassilaki I, B\u00e4ckberg M, Lapins J (2017a) Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. Br J Dermatol 176:1021\u20131027","journal-title":"Br J Dermatol"},{"key":"134_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/15563650.2017.1303141","volume":"55","author":"A Helander","year":"2017","unstructured":"Helander A, B\u00e4ckberg M, Signell P, Beck O (2017b) Intoxications involving acrylfentanyl and other novel designer fentanyls \u2013 results from the Swedish STRIDA project. Clin Toxicol (Phila) 55:589\u2013599","journal-title":"Clin Toxicol (Phila)"},{"key":"134_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpba.2014.07.026","volume":"100","author":"M Johansson","year":"2014","unstructured":"Johansson M, Fransson D, Rundlof T, Huynh NH, Arvidsson T (2014) A general analytical platform and strategy in search for illegal drugs. J Pharm Biomed Anal 100:215\u2013229","journal-title":"J Pharm Biomed Anal"},{"key":"134_CR29","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2169\/internalmedicine.53.2344","volume":"53","author":"Y Kamijo","year":"2014","unstructured":"Kamijo Y, Takai M, Fujita Y, Hirose Y, Iwasaki Y, Ishihara S, Yokoyama T, Yagi K, Sakamoto T (2014) A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med 53:2439\u20132445","journal-title":"Intern Med"},{"key":"134_CR30","first-page":"1954","volume":"109","author":"E Lindeman","year":"2012","unstructured":"Lindeman E, Hulten P, Str\u00f6m S, Enlund M, Al-Saffar Y, Helander A (2012) \u00d6kat missbruk av Internetdrogen MDPV i V\u00e4stmanland. Sv\u00e5ra f\u00f6rgiftningsfall har gett sjukv\u00e5rden stora problem. Lakartidningen 109:1954\u20131957","journal-title":"Lakartidningen"},{"key":"134_CR31","first-page":"1712","volume":"111","author":"E Lindeman","year":"2014","unstructured":"Lindeman E, B\u00e4ckberg M, Personne M, Helander A (2014) MT-45 \u2013 a dangerous and potentially ototoxic internet drug. Lakartidningen 111:1712\u20131715","journal-title":"Lakartidningen"},{"key":"134_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.forsciint.2009.06.008","volume":"191","author":"R Lindigkeit","year":"2009","unstructured":"Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58\u201363","journal-title":"Forensic Sci Int"},{"key":"134_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/156802608783498014","volume":"8","author":"KS Marriott","year":"2008","unstructured":"Marriott KS, Huffman JW (2008) Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr Top Med Chem 8:187\u2013204","journal-title":"Curr Top Med Chem"},{"key":"134_CR34","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1007\/s00216-016-9439-6","volume":"408","author":"MR Meyer","year":"2016","unstructured":"Meyer MR, Pettersson Bergstrand M, Helander A, Beck O (2016) Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Anal Bioanal Chem 408:3571\u20133591","journal-title":"Anal Bioanal Chem"},{"key":"134_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00414-016-1358-8","volume":"130","author":"I Ojanper\u00e4","year":"2016","unstructured":"Ojanper\u00e4 I, Kriikku P, Vuori E (2016) Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med 130:1209\u20131216","journal-title":"Int J Legal Med"},{"key":"134_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/15563659809028940","volume":"36","author":"HE Persson","year":"1998","unstructured":"Persson HE, Sj\u00f6berg GK, Haines JA, Pronczuk de Garbino J (1998) Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 36:205\u2013213","journal-title":"J Toxicol Clin Toxicol"},{"key":"134_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/dta.2003","volume":"9","author":"M Pettersson Bergstrand","year":"2017","unstructured":"Pettersson Bergstrand M, Helander A, Hansson T, Beck O (2017a) Detectability of designer benzodiazepines in CEDIA, EMIT II plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal 9:640\u2013645","journal-title":"Drug Test Anal"},{"key":"134_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/dta.2243","volume":"10","author":"M Pettersson Bergstrand","year":"2017","unstructured":"Pettersson Bergstrand M, Meyer MR, Beck O, Helander A (2017b) Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry. Drug Test Anal 10:496\u2013506","journal-title":"Drug Test Anal"},{"key":"134_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.forsciint.2015.01.003","volume":"248","author":"KW Simonsen","year":"2015","unstructured":"Simonsen KW, Edvardsen HM, Thelander G, Ojanper\u00e4 I, Thordardottir S, Andersen LV, Kriikku P, Vindenes V, Christoffersen D, Delaveris GJ, Frost J (2015) Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int 248:172\u2013180","journal-title":"Forensic Sci Int"},{"key":"134_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3171\/jns.1988.69.5.0699","volume":"69","author":"JE Starmark","year":"1988","unstructured":"Starmark JE, St\u00e5lhammar D, Holmgren E, Rosander B (1988) A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg 69:699\u2013706","journal-title":"J Neurosurg"},{"key":"134_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jms.3946","volume":"52","author":"NN Stephanson","year":"2017","unstructured":"Stephanson NN, Signell P, Helander A, Beck O (2017) Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing \u2013 a step towards a \u2018black-box\u2019 solution? J Mass Spectrom 52:497\u2013506","journal-title":"J Mass Spectrom"},{"key":"134_CR42","unstructured":"UNODC (2017) Fentanyl and its analogues \u2013 50 years on. \n                  https:\/\/www.unodc.org\/documents\/scientific\/Global_SMART_Update_17_web.pdf"},{"key":"134_CR43","unstructured":"WHO (2014) Community management of opioid overdose. \n                  http:\/\/apps.who.int\/iris\/bitstream\/10665\/137462\/1\/9789241548816_eng.pdf?ua=1&ua=1"}],"container-title":["Handbook of Experimental Pharmacology","New Psychoactive Substances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2018_134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T15:52:14Z","timestamp":1558021934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2018_134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783030105600","9783030105617"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/164_2018_134","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"23 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}